Products

What will AGI do for Ameltolide?

This classification denotes an anticonvulsant agent with the molecular formula C15H16N2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier F83240ZOVE, chemically known as 4-amino-n-(2,6-dimethylphenyl)benzamide but generally known as ameltolide, which bears US NIH Compound Identifier 13086. European Medicines Agency schedules Ameltolide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05408MIG. The term AMELTOLIDE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 5, No. 3 1991, List 31). AMELTOLIDE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule ameltolide under HS 29242995 and SITC 51479. As of Q4 2014, AMELTOLIDE remains the US FDA Preferred Term for this commodity. Ameltolide bears US NLM identifiers UMLS ID C0065310 and NCI Concept Code C81472. SMILES: O=C(NC1C(CCCC1C)C)C1CCC(N)CC1.